Among GLP-1 medications specifically, semaglutide has one of the longest half-lives: Exenatide (Byetta): approximately 2.4 hours, requires twice-daily injections Liraglutide (Saxenda, Victoza): approximately 13 hours, requires once-daily injections Dulaglutide (Trulicity): approximately 5 days, requires once-weekly injections Semaglutide (Ozempic, Wegovy): approximately 7 days, requires once-weekly injections Tirzepatide (Mounjaro, Zepbound): approximately 5 days, requires once-weekly injections Semaglutides seven-day half-life ties it with dulaglutide for the longest among currently approved GLP-1 medications
These often occur within the first few weeks of treatment
Some individuals may experience more severe side effects, such as kidney injury, cardiovascular disease, and severe pain
For stroke survivors, the road to recovery can feel uncertain, especially when living with other health challenges like type 2 diabetes and obesity
Timing your injection Semaglutide is administered once weekly on the same day each week
Most patients achieve 5-15% body weight reduction within six months, with some reaching higher percentages through extended treatment and lifestyle optimization